Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report)’s stock price gapped up prior to trading on Wednesday after JPMorgan Chase & Co. raised their price target on the stock from $8.00 to $9.00. The stock had previously closed at $8.86, but opened at $10.24. JPMorgan Chase & Co. currently has a neutral rating on the […]